Oneness Biotech Co Ltd - Company Profile

Powered by

All the data and insights you need on Oneness Biotech Co Ltd in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Oneness Biotech Co Ltd Strategy Report

  • Understand Oneness Biotech Co Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Oneness Biotech Co Ltd: Overview

Select Item

Oneness Biotech Co Ltd (Oneness Biotech) is a biopharmaceutical company. The company's product pipeline comprises ON101 against diabetic foot ulcers, FB825 for atopic dermatitis and allergic asthma, FB704A against severe asthma, OB318 against cancer and FB918 against asthma. It offers products in the therapeutic areas of dermatology, immunology and infectious diseases, among others. Oneness Biotech is headquartered in Taipei, Taiwan.

 Gain a 360-degree view of Oneness Biotech Co Ltd and make more informed decisions for your business Gain a 360-degree view of Oneness Biotech Co Ltd and make more informed decisions for your business Find out more
Headquarters Taiwan
Address 7f-1, No. 3-1, Yuan Qu Street, San Chong Li, Nangang District, Taipei, 106
Website www.onenessbio.com/tc/index.htm
Telephone 886 2 27031098
No of Employees 43
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange 4743 (TPO)
Revenue (2022) $35.8M
EPS XYZ
Market Cap* $2.2B
Net Profit Margin (2023) XYZ -4,578.5%
   
* As of and is in US$
View Oneness Biotech Co Ltd financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Oneness Biotech Co Ltd premium industry data and analytics

20+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Oneness Biotech Co Ltd’s relevant decision makers and contact details.

20+

Clinical Trials

Determine Oneness Biotech Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Catalyst Calendar

Proactively evaluate Oneness Biotech Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

16+

Pipeline Drugs

Identify which of Oneness Biotech Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Oneness Biotech Co Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
Pipeline
Fespixon Cream
ON101
XYZ
XYZ
XYZ
Understand Oneness Biotech Co Ltd portfolio and identify potential areas for collaboration Understand Oneness Biotech Co Ltd portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Oneness Biotech Co Ltd Lotus Pharmaceutical Co Ltd Orient Europharma Co Ltd Savior Lifetec Corp Innopharmax Inc
Headquarters Taiwan Taiwan Taiwan Taiwan Taiwan
City Taipei Taipei Taipei Jhunan Taipei
No. of Employees 43 1,099 800 384 48
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Shan-Ney Huang Chairman Executive Board - -
William Lu Chief Executive Officer Senior Management - -
Nien Yi Chen Vice President Senior Management - -
Shyi Gen Chen Vice President Senior Management - -
Nina Wang Vice President Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Oneness Biotech Co Ltd key executives to enhance your sales strategy Gain insight into Oneness Biotech Co Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward